W C Pugh studies the role of specific proteins and genes in the regulation of insulin-producing cells in the pancreas. His research looks at how these cellular processes contribute to diabetes, especially forms that have a genetic basis, such as MODY3. For instance, he investigates how mutations in the HNF-1alpha gene can lead to failures in insulin secretion, resulting in high blood sugar levels. His work also explores the involvement of calpains in how effectively the body uses insulin and how mutations in other genes can affect the health of pancreatic cells over time.
Key findings
Mice without normal HNF-1alpha had higher blood sugar levels due to inadequate growth of insulin-producing cells, highlighting its critical role in diabetes development.
Blocking calpain proteins resulted in higher insulin release from the pancreas but made other cells less responsive to insulin, suggesting calpains are crucial for insulin control.
Mice with excess Bcl-x(L) prevented cell death but suffered from poor blood sugar control due to disrupted mitochondrial function, showing the delicate balance needed in insulin production.
In a study of mice prone to type 1 diabetes, researchers found that about 40-70% of insulin-producing cells were lost before the onset of diabetes at 18 weeks, indicating a gradual disease progression.
Complete loss of HNF-1alpha in certain mice led to high blood sugar due to inadequate insulin release despite having a normal number of insulin-producing cells, revealing why this gene is important for diabetes management.
Frequently asked questions
Does W C Pugh study diabetes?
Yes, W C Pugh studies diabetes, focusing on how specific proteins and genes affect insulin production and pancreatic cell function.
What treatments has W C Pugh researched?
Pugh's research may help develop treatments aimed at slowing the destruction of insulin-producing cells or enhancing their regeneration, particularly in genetic forms of diabetes.
Is W C Pugh's work relevant to type 1 diabetes?
Yes, his studies investigate the mechanisms behind beta-cell loss in type 1 diabetes, which can inform potential therapies.
Publications in plain English
Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo.
2017
Oral oncology
Alexander-Bryant AA, Zhang H, Attaway CC, Pugh W, Eggart L +5 more
Plain English This study looked at a new method for delivering treatments to oral cancer cells that have too much of a specific protein called EGFR. Researchers found that using a special combination of two peptides helped better deliver small interfering RNAs (siRNAs) directly into these cancer cells, leading to a significant reduction in a target protein associated with cancer growth. This approach improved the targeting of the treatment, showing promising results in mice, with a specific delivery ratio of 60:30:1 for optimal effectiveness.
Who this helps: This benefits patients with oral cancer by potentially providing a more effective treatment option.
The application of discriminant analysis and Machine Learning methods as tools to identify and classify compounds with potential as transdermal enhancers.
2012
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Moss GP, Shah AJ, Adams RG, Davey N, Wilkinson SC +2 more
Plain English This study looked at various methods, including Machine Learning, to better classify and predict how effective certain chemical compounds are at helping drugs pass through the skin. The results showed that the Machine Learning approach, particularly using Gaussian process regression, accurately identified 8 out of 12 effective enhancers and 56 out of 59 poor ones. This is important because it can lead to more reliable predictions of which compounds will enhance drug absorption, reducing the chances of errors in identifying effective treatments.
Who this helps: Patients needing better transdermal drug delivery options.
How sharp can a screening tool be? A qualitative study of patients' experience of completing a bowel cancer screening questionnaire.
2011
Health expectations : an international journal of public participation in health care and health policy
Pugh W, Porter AM
Plain English This study looked at how patients feel about filling out a questionnaire used to screen for bowel cancer. Researchers found that while the questionnaire is generally useful, some patients had trouble with confusing medical terms and questions that were hard to answer. These minor issues could affect how accurately the questionnaire works and how satisfied patients are with the process.
Who this helps: This benefits patients and doctors by improving the screening experience and accuracy.
Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption.
2010
Drug development and industrial pharmacy
Gullick DR, Pugh WJ, Ingram MJ, Cox PA, Moss GP
Plain English This study developed a new skin patch that uses a modified version of captopril, an existing medication for high blood pressure, to release the drug more effectively through the skin. The researchers found that thicker patches allowed for more of the drug to be absorbed, achieving important medical levels in tests. This matters because it could improve how patients receive their medication without needing to take pills.
Who this helps: This helps patients with high blood pressure who may benefit from easier and more effective medication delivery.
Metabolism of captopril carboxyl ester derivatives for percutaneous absorption.
2009
The Journal of pharmacy and pharmacology
Gullick DR, Ingram MJ, Pugh WJ, Cox PA, Gard P +2 more
Plain English Researchers studied how captopril carboxyl derivatives (a form of the blood pressure medication) are absorbed through the skin and how effectively they work as drugs. They found that these derivatives are metabolized slowly, with the ethyl ester being the fastest. All the derivatives inhibited an enzyme related to blood pressure, with the methyl ester being the most effective. This is important because it could lead to better skin-based treatments for managing high blood pressure.
Who this helps: This research benefits patients who need effective options for blood pressure management without oral medication.
The application of Gaussian processes in the prediction of percutaneous absorption.
2009
The Journal of pharmacy and pharmacology
Moss GP, Sun Y, Prapopoulou M, Davey N, Adams R +2 more
Plain English This study looked at how well different methods can predict how substances are absorbed through the skin. Researchers found that using a technique called Gaussian processes leads to more accurate predictions than older methods, especially when dealing with complex substances. For example, this new model performed better with substances that are heavier and less soluble than what previous models could handle.
Who this helps: This helps researchers and doctors working on drug delivery methods.
Role of HNF-1alpha in regulating the expression of genes involved in cellular growth and proliferation in pancreatic beta-cells.
2009
Diabetes research and clinical practice
Uchizono Y, Baldwin AC, Sakuma H, Pugh W, Polonsky KS +1 more
Plain English Researchers created genetically modified mice to study how a protein called HNF-1alpha controls the growth of insulin-producing cells in the pancreas—the same protein that malfunctions in people with a form of inherited diabetes (MODY3). They found that mice lacking normal HNF-1alpha couldn't grow enough of these insulin-producing cells and had higher blood sugar levels as a result. The study reveals that HNF-1alpha controls multiple genes that tell pancreatic cells when to grow and multiply, explaining why mutations in this protein cause diabetes in humans.
Transdermal delivery enhancement of haloperidol from gel formulations by 1,8-cineole.
2008
The Journal of pharmacy and pharmacology
Elgorashi AS, Heard CM, Niazy EM, Noureldin OH, Pugh WJ
Plain English This study looked at improving the delivery of the medication haloperidol through the skin using a gel that contains 10% 1,8-cineole. When tested on human, rabbit, and hairless mouse skin, the gels showed that the delivery of haloperidol was significantly increased; specifically, it was 6.2 times more effective on human skin compared to the gel without cineole. This is important because it suggests that using 1,8-cineole can make transdermal treatments more effective, potentially improving how well patients receive their medication.
Who this helps: This benefits patients who need effective transdermal delivery of medications.
Sustained expression of hepatocyte nuclear factor-6 leads to loss of pancreatic beta-cells by apoptosis.
2007
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Hara M, Shen J, Pugh W, Polonsky KS, Le Beau MM +1 more
Plain English This study looked at the role of a protein called HNF-6 in pancreatic beta-cells, which produce insulin. The researchers created mice that had high levels of HNF-6 and found that, by six weeks of age, these mice lost about 30% of their beta-cells due to a process called programmed cell death, also known as apoptosis. These findings are important because they suggest that high levels of HNF-6 might contribute to problems with insulin production, which is a key issue in diabetes.
Who this helps: This helps doctors and researchers studying diabetes and finding new treatments.
Gastroretentive dosage forms: overview and special case of Helicobacter pylori.
2006
Journal of controlled release : official journal of the Controlled Release Society
Bardonnet PL, Faivre V, Pugh WJ, Piffaretti JC, Falson F
Plain English This study looks at ways to improve medications that stay in the stomach longer to better treat infections caused by Helicobacter pylori, a bacteria linked to stomach ulcers. Researchers reviewed various methods to create these long-lasting medications, such as floating capsules and special gels, and highlighted targeted approaches specifically for H. pylori. These advancements are important because they can lead to more effective treatments for stomach infections, potentially improving patient recovery.
Who this helps: This helps patients with stomach infections, especially those caused by H. pylori.
Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
2006
The Journal of pharmacy and pharmacology
Moss GP, Gullick DR, Cox PA, Alexander C, Ingram MJ +2 more
Plain English This study focused on improving the way a drug called captopril is absorbed through the skin, rather than taken by mouth, to provide more steady levels in the bloodstream. Researchers created modified versions of captopril and found that these new forms could be absorbed through the skin more effectively, especially those with specific structures, with the best results for certain types of esters. This is important because it could lead to better treatment options for patients who need consistent medication levels without the side effects of oral intake.
Who this helps: Patients who need stable medication levels for blood pressure and heart issues.
Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers.
2005
The Journal of pharmacy and pharmacology
Pugh WJ, Wong R, Falson F, Michniak BB, Moss GP
Plain English This study investigated different chemical compounds to see which ones could help increase the absorption of hydrocortisone through hairless mouse skin. Researchers tested 73 compounds and found that some were much more effective than others, with enhancement ratios ranging from 0.2 to 25.3, indicating how well they improved absorption. They discovered that compounds with longer carbon chains and a certain number of hydrogen bonding atoms were more likely to be effective, and used a method called discriminant analysis to accurately identify most of the top-performing enhancers.
Who this helps: Patients needing better medication absorption through their skin.
Simple rules defining the potential of compounds for transdermal delivery or toxicity.
2004
Pharmaceutical research
Magnusson BM, Pugh WJ, Roberts MS
Plain English This study looked at how certain chemical properties of substances affect their ability to pass through the skin, either quickly or slowly, and how toxic they might be. Researchers analyzed data on 87 different substances and created simple rules to classify them based on their properties. They found that 70% of the substances could be accurately classified, meaning they can effectively identify which ones are likely to be good or bad at penetrating skin, helping in the development of better drug delivery methods.
Who this helps: This helps patients, particularly those using skin-administered medications.
Topical delivery of retinyl ascorbate co-drug. 2. Comparative skin tissue and keratin binding studies.
2004
Skin pharmacology and physiology
Abdulmajed K, Heard CM, McGuigan C, Pugh WJ
Plain English This study examined how well a combination of vitamins A and C, known as retinyl ascorbate, sticks to different types of skin and keratin (a key protein in skin) to understand how effective it might be as a skin treatment. Researchers found that retinyl ascorbate binds better to human skin than to pig or cow skin, and polar substances like vitamin C have different binding behaviors influenced by the fat content in the skin—more fat can help some compounds stick but hurt others. These findings are important because they help develop better topical treatments for protecting skin from sun damage and promoting healthy cell growth.
Who this helps: This helps patients looking for effective skincare products.
Receptor regulatory properties evident in the molecular similarity of serotonin receptor ligands and purine nucleotides.
2004
The Journal of pharmacy and pharmacology
Williams WR, Pugh WJ, Nicholls PJ
Plain English This study looked at how certain molecules that interact with serotonin receptors (which are important for many brain functions) are similar to molecules found in energy-carrying compounds like ATP. The researchers found that specific parts of these molecules could act on different types of serotonin receptors, suggesting that they could influence how the brain communicates using serotonin. Understanding these connections can help in developing better drugs for conditions like depression or anxiety.
Who this helps: This helps patients with mental health conditions and the doctors treating them.
Effect of vehicle pretreatment on the flux, retention, and diffusion of topically applied penetrants in vitro.
2003
Pharmaceutical research
Rosado C, Cross SE, Pugh WJ, Roberts MS, Hadgraft J
Plain English This study looked at how different skin creams and gels affect the absorption of drugs applied to the skin. Researchers tested four substances and found that using thicker, more oily creams significantly increased the amount of drug that penetrated the skin. For example, the enhancement was most noticeable with the oily options, while a drug called diazepam didn't absorb better since it already penetrated the skin effectively.
Who this helps: This research benefits patients needing topical medications, especially those using less effective creams.
The effect of the nature of H-bonding groups on diffusion through PDMS membranes saturated with octanol and toluene.
2002
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Du Plessis J, Pugh WJ, Judefeind A, Hadgraft J
Plain English This study looked at how different compounds travel through silicone membranes that were either soaked in toluene or octanol. When soaked in octanol, the membranes slowed down the movement of these compounds, indicating that the presence of polar hydrogen bonding affects how easily they can pass through. Specifically, the movement of the compounds was slower in the octanol environment compared to the toluene environment, showing that changing the membrane's properties can significantly impact diffusion rates.
Who this helps: This research benefits scientists and medical professionals who are studying drug delivery through the skin.
Receptor regulatory properties evident in the molecular similarity of dopamine receptor ligands and purine nucleotides.
2002
The Journal of pharmacy and pharmacology
Williams WR, Pugh WJ, Nicholls PJ
Plain English This study looked at the similarities between dopamine receptor ligands (molecules that bind to dopamine receptors) and purine nucleotides (such as ATP and GTP, which are important for cell signaling). The researchers found that certain parts of these molecules have similar structures, suggesting that dopamine receptors may have evolved from receptors that originally interacted with ATP and GTP. These findings can help us better understand how dopamine receptors function and their role in communication within the brain.
Who this helps: This helps researchers and medical professionals looking to develop new treatments for neurological conditions related to dopamine receptors.
Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component.
2002
Diabetes
Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L +5 more
Plain English This study looked at the effects of Panax ginseng berry extract on obesity and diabetes in mice. After 12 days of treatment, the mice that received the extract had normal blood sugar levels and significantly improved glucose tolerance, with a 46% reduction in their glucose response compared to untreated mice. They also lost weight, reduced their appetite, and burned more energy, while cholesterol levels decreased. Importantly, a key component of the extract, ginsenoside Re, was identified as playing a significant role in controlling blood sugar.
Who this helps: This research benefits patients with obesity and diabetes by offering insights into natural treatments for managing their conditions.
Physico-chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups.
2002
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
du Plessis J, Pugh WJ, Judefeind A, Hadgraft J
Plain English This study looked into how the structure of certain chemicals, specifically phenols, affects their ability to penetrate human skin. Researchers found that phenols with more -OH groups generally moved through the skin faster, especially when the chemical structure was less symmetrical. For example, a compound with three -OH groups diffused more quickly than one with fewer groups, highlighting that symmetry and the number of -OH groups play crucial roles in drug delivery through the skin.
Who this helps: This information benefits patients needing topical medications, as it can guide the development of more effective skin treatments.
The effect of hydrogen bonding on diffusion across model membranes: consideration of the number of H-bonding groups.
2001
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Du Plessis J, Pugh WJ, Judefeind A, Hadgraft J
Plain English This study looked at how well certain chemicals, called phenols, move through membranes that act like human skin when they have hydrogen bonding groups added. The researchers found that as they increased the number of these hydrogen bonding groups, the movement of the phenols through the membranes slowed down, especially in membranes soaked with octanol. Understanding this can help in figuring out how substances are absorbed through the skin or other biological membranes.
Who this helps: Patients who need better drug delivery options through the skin.
A virtual reality patient simulation system for teaching emergency response skills to U.S. Navy medical providers.
2001
Prehospital and disaster medicine
Freeman KM, Thompson SF, Allely EB, Sobel AL, Stansfield SA +1 more
Plain English This study focused on creating a virtual reality training system to help U.S. Navy medical providers improve their emergency response skills in high-pressure situations, like disasters. The new system combines 3D virtual reality with traditional screen interfaces, allowing trainees to practice diagnosing and treating complex injuries without risk. This hands-on approach helps them learn quickly and effectively, mastering their skills even in challenging environments.
Who this helps: This benefits Navy medical providers and enhances their ability to care for patients in emergencies.
Review of the Naval Health Research Center's development of medical information systems for far-forward echelons of care, 1983 to 1997.
2001
Military medicine
Tropeano AM, Pugh WM
Plain English This research reviewed how the Naval Health Research Center worked from 1983 to 1997 to improve medical information systems for military medical care in the field. They found that automated systems could improve patient documentation and tracking, allowing more medical staff to focus on treating patients rather than paperwork. The improvements included using new prototypes that helped streamline processes, which is important for providing timely and effective care in combat situations.
Who this helps: This benefits military personnel and healthcare providers in the field.
Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes.
2001
Pharmaceutical research
Cross SE, Pugh WJ, Hadgraft J, Roberts MS
Plain English This study looked at how different solvents affect the absorption and delivery of hydrocortisone, a medication used to reduce inflammation, through silicone membranes. The researchers found that they could predict how well solvents would help hydrocortisone penetrate the membrane based on the solvents' physical properties, with a strong correlation (r2=0.76) between solvent absorption and hydrocortisone delivery. Understanding this relationship is important for improving the effectiveness of topical medications.
Who this helps: This helps patients who use topical medications for skin conditions.
Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.
2001
Nature medicine
Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B +4 more
Plain English This study looked at how a protein called Akt1 affects the growth and survival of insulin-producing cells in the pancreas. Researchers found that increasing Akt1 levels in mouse beta cells made these cells bigger, increased the overall mass of insulin-producing clusters, and led to better control of blood sugar, preventing diabetes in these mice. This is important because it could help us develop new treatments for diabetes by enhancing the function of pancreatic cells.
Who this helps: This helps patients with diabetes.
Plain English Researchers found that blocking calpain proteins—which are found throughout the body—causes pancreases to release more insulin in response to high blood sugar, and simultaneously makes muscles and fat cells less responsive to insulin's signals. Since genetic variations in the calpain-10 gene are linked to type 2 diabetes, these results suggest that calpains are a key control point for how much insulin the body makes and how well cells use it.
Epidermal permeability-penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge.
2000
International journal of pharmaceutics
Pugh WJ, Degim IT, Hadgraft J
Plain English This study looked at how different molecular properties affect the ability of substances to pass through the outer layer of human skin (the stratum corneum). Researchers found that the best way to predict how easily a substance can diffuse through this layer is by considering both its molecular weight and its electrical charge, which together make a significant impact on its movement. Specifically, they discovered that these two factors accounted for a large portion of the variations observed in the data, with the combination of molecular weight and charge being the best indicators.
Who this helps: This benefits researchers and pharmaceutical companies developing topical medications.
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
2000
Annals of oncology : official journal of the European Society for Medical Oncology
López-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F +7 more
Plain English This study looked at how well patients with a slow-growing type of lymphoma called follicular lymphoma fare based on their response to treatment. Researchers found that out of 116 patients, 80 (about 69%) had a negative test for cancer in their blood within the first year, and these patients had a significant survival advantage, with a five-year failure-free survival rate of 73% compared to just 28% for those who didn't respond as well. Understanding these factors helps doctors determine which patients are likely to do better with treatment.
Who this helps: This benefits patients with follicular lymphoma and their doctors.
Plain English This study looked at how a hormone called glucagon-like peptide-1 (GLP-1) affects insulin release in two types of rats: diabetic Zucker fatty rats and their lean counterparts. The researchers found that while the lean rats responded to GLP-1 and increased insulin secretion when glucose levels were high, the diabetic rats didn't show a significant response to glucose but did increase insulin secretion when exposed to GLP-1. This difference is essential because it helps us understand how insulin release works differently in diabetic conditions, which can inform treatment strategies for diabetes.
Who this helps: This information is valuable for doctors treating diabetic patients.
Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion.
2000
American journal of physiology. Endocrinology and metabolism
Zhou YP, Pena JC, Roe MW, Mittal A, Levisetti M +9 more
Plain English Researchers created mice with extra copies of a protein called Bcl-x(L) in their pancreas to see if it would protect insulin-producing cells from dying. While the protein did prevent cell death as expected, mice with very high levels of the protein developed severe problems with blood sugar control because their pancreatic cells couldn't properly use glucose to generate the energy signal needed to release insulin. The underlying problem was that the extra protein disrupted how mitochondria (the cell's power plants) work, preventing them from processing glucose and creating the chemical signals that trigger insulin release.
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
1999
Blood
López-Guillermo A, Cabanillas F, McDonnell TI, McLaughlin P, Smith T +8 more
Plain English This study looked at how changes in a specific gene (bcl-2) relate to the characteristics and outcomes of patients with a type of slow-growing lymphoma called follicular lymphoma (FL). Researchers found that out of 247 patients, those with a rearrangement at the major breakpoint region had a better survival rate compared to those with no rearrangement or those with a rearrangement at the minor cluster region. Specifically, the chances of staying free from the disease after three years were 95% for minor cluster, 76% for major breakpoint, and only 57% for patients without any rearrangement, indicating the importance of these genetic markers in guiding treatment decisions.
Who this helps: This helps patients with follicular lymphoma and their doctors make better treatment choices based on genetic information.
Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.
1999
International journal of radiation oncology, biology, physics
Logsdon MD, Meyn RE, Besa PC, Pugh WC, Stephens LC +7 more
Plain English This study looked at how levels of cell death (apoptosis) and certain proteins (Bcl-2, Bax, and Bcl-x) in tumor samples from patients with early-stage follicular center lymphoma (FCL) relate to patient outcomes. Researchers analyzed data from 144 patients and found that a lower level of apoptosis (less than 0.4) was linked to better survival rates and lower chances of cancer returning for those treated with combined chemotherapy and radiation (CMT). Understanding these factors helps doctors predict how well patients with localized FCL will respond to treatment.
Who this helps: This helps patients with follicular center lymphoma and their healthcare providers.
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
1999
Annals of oncology : official journal of the European Society for Medical Oncology
Sarris AH, Kliche KO, Pethambaram P, Preti A, Tucker S +12 more
Plain English This study focused on measuring levels of a protein called interleukin-10 (IL-10) in the blood of adults with Hodgkin's disease to see how it affects their chances of staying free from cancer after treatment. The researchers found that 51 out of 101 patients had elevated IL-10 levels, which were linked to a significantly lower success rate in avoiding cancer recurrence: only 60% of those with high IL-10 levels remained cancer-free after three years, compared to 91% of those with normal levels. This is important because understanding IL-10 levels may help doctors predict patient outcomes better and tailor treatments for those at higher risk.
Who this helps: This helps doctors and patients by providing insights into treatment effectiveness and guiding decisions for Hodgkin's disease management.
Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
1999
Metabolism: clinical and experimental
Zhou YP, Cockburn BN, Pugh W, Polonsky KS
Plain English This study looked at how certain rats, which are prone to diabetes and obesity, release insulin in their bodies. The researchers found that these rats had insulin levels that were two to four times higher than healthy rats, even in low glucose conditions. Additionally, the high insulin release was mainly due to changes in fuel metabolism, not just the regular secretion process.
Who this helps: This benefits researchers and healthcare professionals looking to understand diabetes better.
Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse.
1999
Diabetes
Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W +1 more
Plain English Researchers studied mice prone to type 1 diabetes to understand how they lose the insulin-producing cells in their pancreas. They found that these mice start losing beta cells gradually over several weeks—even before showing signs of diabetes—and their bodies try to compensate by growing new beta cells faster than normal, but this isn't enough to keep up with the destruction.
By the time diabetes appeared, the mice had lost about 70% of their beta cells and couldn't produce enough insulin, which is why their blood sugar skyrocketed. This matters because it shows diabetes doesn't happen suddenly; it's a slow decline in beta cell numbers and function that the body fails to overcome.
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
1998
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Popat U, Przepiork D, Champlin R, Pugh W, Amin K +15 more
Plain English This study looked at how well patients with a specific type of cancer called diffuse large B-cell lymphoma (DLBCL) respond to high-dose chemotherapy and stem cell transplants. Out of 90 patients treated, those with primary mediastinal lymphoma (34% of the group) tended to have better outcomes. Specifically, 40% were disease-free five years later, and overall survival was 42%. This is important because it suggests that patients with primary mediastinal lymphoma might respond better to treatment than those with other types of DLBCL.
Who this helps: This helps patients with primary mediastinal lymphoma and their doctors in making treatment decisions.
The clinical significance of molecular response in indolent follicular lymphomas.
1998
Blood
López-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F +7 more
Plain English This study looked at patients with indolent follicular lymphoma (FL) to see how well they respond to treatment based on a specific genetic marker called bcl-2. Researchers found that 66% of patients had a positive molecular response by 15 to 18 months after starting treatment, and those who achieved this response early had a much better chance of not having the disease return—76% of these patients were still doing well after four years compared to just 38% who did not achieve a molecular response. This research is important because it helps doctors identify which patients are more likely to stay cancer-free after treatment.
Who this helps: Patients with follicular lymphoma and their doctors.
The field hospital at Zagreb: tri-service medical care in a peacekeeping operation.
1998
Military medicine
Reed RJ, Martino J, Eyestone SM, Pugh WM
Plain English This study looked at about 16,000 medical records from a field hospital in Zagreb, Croatia, to help military planners better understand what resources and skills are needed for humanitarian missions. Researchers found out who the patients were, what health issues they had, and how services were used among different groups. This information is crucial for improving medical support in future peacekeeping efforts.
Who this helps: This helps military planners and medical teams involved in humanitarian missions.
Plain English This study focused on a specific genetic change called t(2;5) that is often found in a type of cancer known as anaplastic large cell lymphoma (ALCL). Researchers found this genetic change in 6 out of 38 ALCL samples they tested (which is 16%), but it wasn’t present in any of the other lymphoma types they studied. This is important because detecting t(2;5) can help doctors identify and diagnose ALCL more accurately.
Who this helps: Patients with ALCL and their doctors.
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.
1998
Leukemia & lymphoma
Daliani D, Ulmer RA, Jackow C, Pugh W, Gansbacher B +3 more
Plain English Researchers studied the role of certain proteins in the skin condition known as cutaneous T-cell lymphoma (CTCL) in 19 adults who did not have the HTLV-I virus. They found that two proteins, TNF-alpha and IFN-gamma, were likely responsible for attracting immune cells to the skin lesions, while another protein related to HTLV-I was not present in these patients. This is important because understanding these factors can help improve the treatment and management of CTCL.
Who this helps: This helps patients with cutaneous T-cell lymphoma.
The selection and design of topical and transdermal agents: a review.
1998
The journal of investigative dermatology. Symposium proceedings
Hadgraft J, Pugh WJ
Plain English This study looked at how medications applied to the skin can better penetrate the outer skin layer, known as the stratum corneum. Researchers found that drugs meant for skin application need to be specifically designed rather than just adapted from oral medications to be more effective. Understanding how these medications work at a molecular level can lead to the development of stronger and more varied treatments delivered through the skin.
Who this helps: This benefits patients who need effective topical or transdermal medications.
Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
1998
Hematopathology and molecular hematology
Luthra R, Pugh WC, Waasdorp M, Morris W, Cabanillas F +2 more
Plain English This study focused on a specific genetic change, known as the t(2;5) fusion, that occurs in patients with anaplastic large cell lymphoma (ALCL). The researchers found that the break points in the DNA where this fusion occurs are unique to each patient, indicating that these genetic changes can vary significantly. This matters because understanding these unique genetic markers can help in tracking the disease and monitoring treatment effectiveness.
Who this helps: This benefits patients with ALCL and their doctors, as it improves monitoring and treatment strategies tailored to individual genetic profiles.
The clinical behavior of localized and multicentric Castleman disease.
1998
Annals of internal medicine
Herrada J, Cabanillas F, Rice L, Manning J, Pugh W
Plain English This study looked at Castleman disease, which can either be localized or multicentric, to understand how it's treated and what the outcomes are for patients. Researchers analyzed data from 15 patients at a medical facility in Texas and found that all 7 patients with localized Castleman disease were cured through surgery, while among the 8 with multicentric disease, only those treated with chemotherapy were free of disease, whereas others needed ongoing treatment or sadly passed away. This matters because it shows that localized and multicentric Castleman disease need different treatment approaches for better outcomes.
Who this helps: This helps patients with Castleman disease and their doctors make informed decisions about treatment options.
Plain English This study investigated a new treatment plan for aggressive mantle-cell lymphoma, a type of cancer known to have a poor outlook. The researchers found that after the treatment, 93.5% of patients responded positively, with complete recovery in 38% of cases. Notably, untreated patients had a 92% chance of surviving at least three years after the treatment, significantly better than those who had received previous treatments.
Who this helps: This benefits patients with untreated aggressive mantle-cell lymphoma.
Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
1998
Diabetes
Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W +2 more
Plain English This study looked at why diabetes develops in a specific rat model known as the Zucker diabetic fatty (ZDF) rat, focusing on the beta cells that produce insulin. Researchers found that, while young ZDF rats had a beta-cell mass similar to insulin-resistant rats, by 12 weeks the beta-cell mass in ZDF rats dropped significantly to 8.1 mg compared to 15.7 mg in insulin-resistant rats. The study highlights that even though ZDF rats had a higher rate of beta-cell division (0.88%), they still lost beta cells faster due to increased cell death, which is important because it shows that just dividing more isn't enough when the cells are also dying.
Who this helps: This helps researchers and doctors understand diabetes progression, potentially guiding better treatments for patients.
Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.
1998
The Journal of clinical investigation
Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D +10 more
Plain English Researchers studied mice with broken copies of a gene called HNF-1alpha to understand why mutations in this gene cause a form of diabetes in humans. They found that mice completely lacking this gene developed high blood sugar because their pancreas couldn't release enough insulin in response to glucose or other signals, even though they had a normal number of insulin-producing cells. This discovery shows that HNF-1alpha is essential for keeping pancreatic cells able to sense blood sugar and release insulin properly, which explains why people who inherit mutations in this gene develop early-onset diabetes.
Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.
1997
Blood
Melnyk A, Rodriguez A, Pugh WC, Cabannillas F
Plain English This study looked at the Revised European-American Lymphoma classification to see how well it predicts outcomes for patients with aggressive non-Hodgkin's lymphoma. Researchers analyzed data from 560 patients and found that those with peripheral T-cell non-Hodgkin's lymphomas (PTCL) had significantly worse survival rates than those with B-cell lymphomas; only 39% of PTCL patients survived at least five years, compared to 62% for B-cell patients. This matters because it shows that the type of lymphoma a patient has can greatly affect their prognosis and can help doctors make better treatment decisions.
Who this helps: Patients diagnosed with aggressive non-Hodgkin's lymphoma and their doctors.
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
1997
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
van Besien K, Thall P, Korbling M, Pugh WC, Khouri I +12 more
Plain English This study looked at 44 patients with non-Hodgkin's lymphoma (NHL) who underwent a type of stem cell transplant after receiving specific chemotherapy. The results showed that two years after the transplant, only 23% of patients were free from disease, but using donor stem cells reduced the risk of harmful side effects from the treatment. This research highlights the need for better treatment methods to improve outcomes for patients with severe NHL.
Who this helps: This helps patients with non-Hodgkin's lymphoma and their doctors.
Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions.
1997
Letters in applied microbiology
Liau SY, Read DC, Pugh WJ, Furr JR, Russell AD
Plain English This study looked at how silver nitrate interacts with certain amino acids and compounds, particularly those with sulfur groups, to understand its antibacterial effects. It found that silver nitrate lost its ability to kill the bacteria Pseudomonas aeruginosa when it came into contact with sulfur-containing compounds like cysteine, but not with other types of amino acids. This is important because it shows that the presence of sulfur groups can significantly reduce the effectiveness of silver as an antibacterial agent.
Who this helps: This helps doctors and researchers looking for effective treatments against bacterial infections.